Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.21
-0.02 (-0.24%)
At close: Jun 16, 2026, 4:00 PM EDT
8.01
-0.20 (-2.44%)
After-hours: Jun 16, 2026, 7:48 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $536.31 million as of June 16, 2026. Its market cap has increased by 28.51% in one year.
Market Cap
536.31M
Enterprise Value
573.56M
1-Year Change
28.51%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $536.31M, a decrease of -75.42%. That is a compound annual growth rate of -23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 536.31M | 13.55% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 583.96M |
| Achieve Life Sciences | 569.76M |
| Tectonic Therapeutic | 566.26M |
| MiMedx Group | 551.10M |
| Gyre Therapeutics | 531.78M |
| XOMA Royalty | 523.96M |
| Prime Medicine | 518.37M |
| ProKidney | 510.48M |